Insider Trading & Ownership - Edwards Martin

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Edwards Martin
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2023-11-20
Purchase		2023-11-22
5:09 pm		Verona Pharma plcVRNAEdwards Martin
Director		33,736$1.837$61,973144,800
(Direct)		View
2023-11-13
Purchase		2023-11-15
7:00 pm		Morphic Holding Inc.MORFEdwards Martin
Director		2,376$20.54$48,8032,376
(Direct)		View
2021-05-04
Sale		2021-05-05
5:04 pm		Verona Pharma plcVRNAEdwards Martin
Director		12,024$0.8397$10,097111,064
(Direct)		View
2021-02-01
Sale		2021-02-03
7:09 pm		Verona Pharma plcVRNAEdwards Martin
Director		13,688$0.9938$13,603123,088
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2024-08-16
Disposition		2024-08-21
4:36 pm		N/A
2030-12-01		Morphic Holding Inc.MORFEdwards Martin
Director		89,625$00
(Direct)		View
2024-06-18
Option Award		2024-06-20
4:07 pm		N/A
2034-06-17		Inozyme Pharma Inc.INZYEdwards Martin
Director		28,000$028,000
(Direct)		View
2024-06-04
Option Award		2024-06-05
8:21 pm		N/A
2034-06-03		Morphic Holding Inc.MORFEdwards Martin
Director		23,168$023,168
(Direct)		View
2024-04-29
Option Award		2024-04-30
4:17 pm		N/A
2034-04-28		Verona Pharma plcVRNAEdwards Martin
Director		240,000$0240,000
(Direct)		View
2023-09-26
Disposition		2023-09-26
4:30 pm		N/A
2030-08-03		REATA PHARMACEUTICALS INCRETAEdwards Martin
Director		35,961$00
(Direct)		View
2023-06-13
Option Award		2023-06-15
4:05 pm		N/A
2033-06-12		Inozyme Pharma Inc.INZYEdwards Martin
Director		16,000$016,000
(Direct)		View
2023-06-07
Option Award		2023-06-09
4:13 pm		N/A
2033-06-07		REATA PHARMACEUTICALS INCRETAEdwards Martin
Director		169$73.688,422
(Direct)		View
2023-06-07
Option Award		2023-06-09
4:13 pm		N/A
N/A		REATA PHARMACEUTICALS INCRETAEdwards Martin
Director		1,815$93.618,422
(Direct)		View
2023-06-07
Option Award		2023-06-09
4:13 pm		N/A
2033-06-07		REATA PHARMACEUTICALS INCRETAEdwards Martin
Director		2,137$08,422
(Direct)		View
2023-06-01
Option Award		2023-06-05
6:59 pm		N/A
2033-05-31		Morphic Holding Inc.MORFEdwards Martin
Director		12,535$012,535
(Direct)		View
2023-04-28
Option Award		2023-04-28
4:22 pm		N/A
2033-04-27		Verona Pharma plcVRNAEdwards Martin
Director		96,000$096,000
(Direct)		View
2022-06-10
Option Award		2022-06-14
07:48 am		N/A
2032-06-09		Inozyme Pharma Inc.INZYEdwards Martin
Director		9,367$09,367
(Direct)		View
2022-06-08
Option Award		2022-06-10
7:00 pm		N/A
2032-06-07		Morphic Holding Inc.MORFEdwards Martin
Director		17,550$017,550
(Direct)		View
2022-06-08
Option Award		2022-06-09
4:20 pm		N/A
2032-06-08		REATA PHARMACEUTICALS INCRETAEdwards Martin
Director		520$24.0210,441
(Direct)		View
2022-06-08
Option Award		2022-06-09
4:20 pm		N/A
2032-06-08		REATA PHARMACEUTICALS INCRETAEdwards Martin
Director		5,620$010,441
(Direct)		View
2022-06-08
Option Award		2022-06-09
4:20 pm		N/A
N/A		REATA PHARMACEUTICALS INCRETAEdwards Martin
Director		4,242$34.7610,441
(Direct)		View
2022-04-28
Option Award		2022-04-29
4:44 pm		N/A
2032-04-27		Verona Pharma plcVRNAEdwards Martin
Director		200,000$0200,000
(Direct)		View
2021-06-16
Option Award(A)		2022-04-29
4:10 pm		N/A
2031-06-16		Morphic Holding Inc.MORFEdwards Martin
Director		9,996$09,996
(Direct)		View
2022-01-03
Option Award		2022-01-05
4:02 pm		N/A
N/A		REATA PHARMACEUTICALS INCRETAEdwards Martin
Director		59$27.32158
(Direct)		View
2022-01-03
Option Award		2022-01-05
4:02 pm		N/A
2032-01-03		REATA PHARMACEUTICALS INCRETAEdwards Martin
Director		99$16.14158
(Direct)		View
2021-09-30
Option Award		2021-10-04
4:53 pm		N/A
2031-09-29		KalVista Pharmaceuticals Inc.KALVEdwards Martin
Director		10,000$010,000
(Direct)		View
2021-08-09
Option Award		2021-08-10
4:46 pm		N/A
2031-08-08		Verona Pharma plcVRNAEdwards Martin
Director		64,000$064,000
(Direct)		View
2021-06-23
Option Award		2021-06-24
4:17 pm		N/A
2031-06-22		Inozyme Pharma Inc.INZYEdwards Martin
Director		9,367$09,367
(Direct)		View
2021-06-16
Option Award		2021-06-17
7:07 pm		N/A
2031-06-16		Morphic Holding Inc.MORFEdwards Martin
Director		12,000$012,000
(Direct)		View
2021-06-10
Option Award		2021-06-14
4:11 pm		N/A
2031-06-10		REATA PHARMACEUTICALS INCRETAEdwards Martin
Director		5,000$05,000
(Direct)		View

Ownership		2021-01-04
8:37 pm		N/A
N/A		Verona Pharma plcRNAEdwards Martin
Director		0$0136,776
(Direct)		View
2020-12-01
Option Award		2020-12-03
9:49 pm		N/A
2030-12-01		Morphic Holding Inc.MORFEdwards Martin
Director		24,000$024,000
(Direct)		View

Ownership		2020-12-03
9:47 pm		N/A
N/A		Morphic Holding Inc.MORFEdwards Martin
Director		0$00
(Direct)		View
2020-10-01
Option Award		2020-10-02
8:39 pm		N/A
2030-09-30		KalVista Pharmaceuticals Inc.KALVEdwards Martin
Director		7,000$07,000
(Direct)		View
2020-08-03
Option Award		2020-08-04
4:41 pm		N/A
2030-08-03		REATA PHARMACEUTICALS INCRETAEdwards Martin
Director		16,300$016,300
(Direct)		View
2020-07-23
Option Award		2020-07-24
4:49 pm		N/A
2030-07-22		Inozyme Pharma Inc.INZYEdwards Martin
Director		9,367$09,367
(Direct)		View
(A) Indicate amendment filing.